Pharm9 - Pharm9 Flashcards

(60 cards)

1
Q

which receptors are associaed with Gq

A

HAVe 1 M&M H1 alpha 1 V1 M1, M3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which receptors are associated with Gi

A

MAD 2’s M2 alpha 2 D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which receptors are associated with Gs

A

B1, B2, D1, H2, V2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

major fxns of M2

A

decreases HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

major fxns of M3

A

increase exocrine gland secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

major fxns of D1

A

relaxes vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

major fxns of D2

A

modulates transmimtter release in brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

major fxns of H1

A

ubcreases basak abd bronchial mucus production, contraction of bronchioles, pruritis, pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

major fxns of H2

A

increase gastric acid secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

major fxn of V1

A

constricts vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

major fxn of V2

A

increas water permeability and reabsorption in CT of kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA hemicholinium

A

blocks the transport of choline into cholinergic neurons, blocking the production of ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA vesamicol

A

blocks the transporter that brings Acetyl CoA + Choline CHAT into vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA botulinum

A

blocks the release of ACh vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA metyrosine

A

blocks conversion of tyrosine into DA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MOA reserpine

A

blocks DA transporter into vesicles that form NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA guanethidine

A

inhiits release of NorE from noraderenergic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA amphetamine

A

increase release of NorE from vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MOA pralodoxime

A

reactivates AChE after it’s been inhibited by pesticides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

treatment for salicylate OD

A

alkalinize urine dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

treatment of antimuscarinics OD

A

physostigmine salicyate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

treatment of b-blocker od

A

glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

tx of digitalis od

A

stop dig normalize K \lidocaine anti-dig Fab fragments Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

tx iron toxicity

A

deferoxamine (chelating agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
tx fo lead poisoning
EDTA dimercaprol succimer penicillamine
26
tx of arsenic toxicity
dimercaprol succimer
27
tx hg toxicity
dimercaprol succimer
28
tx au toxicity
dimercaproli succimer penicillamine
29
tx cu toxicity
penicillamine
30
tx cn toxicyt
nitrite hydroxocobalamin thiosulfate
31
tx methemoglobin toxicity
methylene blue
32
tx CO toxcity
100% o2, hyperbaric pressure
33
tx of methanol od
ethanol dialysis fomepizole
34
tx of ethylene glycol od
etoh dialysis foempizole
35
tx of opiod toxicity
nalaxone naltrexone
36
tx of benzo od
flumazenil
37
tx of ca od
NaHCO3
38
tx of heparin toxicity
protamine sulfate
39
tx of warfarin toxicity
vitamin k ffp
40
x tpa toxicity
aminocaproic acid
41
tx streptokinase toxicity
aminocaproic acid
42
sx of iron od
fever sweating abdominal pains diarrhea cyanosis weakness
43
examples of insulin drugs (and give duration of action)
lispro (short) insulin (short) NPH (intermediate) lente and ultralente (long acting)
44
clinical uses of insulin analogs
DM I life-threatening hyperkalemia (insulin increases K entry into cells) stress induced hyperglycemia
45
examples of 1st generation sulfonylureas
tolbutaminde chlorpropamide
46
examples of 2nd generation sulfonylureas
glyburide glimepiride glipizide
47
MOA sulfonylureas
when glucose enters the cell, the ATP level rises high ATP:ADP closes K channel this causes Ca influx --> insulin release these drugs enoucrage this process by closing k channels (basically stimulates the release of endogenous insulin)
48
uses of sulfonylureas
DM II reqires some islet cell fxn, so useless in DM I
49
toxicity associated with sulfonylureas (1st gen)
diulfuram effects
50
toxicity associated with 2nd generation sulfonylureas
hypoglycemia
51
examples of biguanides
metformin
52
MOA metformin
unknown, but might decrease gluconeogenesis, increase glycolysis and decrease serum glucose levels
53
clinical use of metformin
can be used in pts without islet cell fxn
54
adverse effects of metformin
lactic acidosis
55
MOA glitazones
incresaes target cell response to insulin
56
clinical use for glitazones
DM II
57
toxicity associated with glitazones
weight gain edema hepatotoxicity
58
examples of alpha-glucosidase inhibitors
acarbose miglitol
59
MOA alpha-glucosidase inhibitors
inhibits intestinal brush border alpha-glucosidases delays sugar hydrolysis and glucose absorption decreased post-prandial hyperglycemia
60
clinical use of alpha glucosidase inhibitors
DM II